Surrogate Matrix
Surrogate Matrix - Related Videos
08:16
Preparation and Analysis of In Vitro Three Dimensional Breast Carcinoma Surrogates
0 Views •
Cited by 6 •
2016
We demonstrate a method to generate 3D breast cancer surrogates, which can be cultured using a perfusion bioreactor system to deliver oxygen and nutrients. Following growth, surrogates are fixed and processed to paraffin for evaluation of parameters of interest. The evaluation of one such parameter, cell density, is explained.
08:37
Microglia as a Surrogate Biosensor to Determine Nanoparticle Neurotoxicity
0 Views •
Cited by 16 •
2016
Microglia (immune cells of the brain), are used as a surrogate biosensor to determine how nanoparticles influence neurotoxicity. We describe a series of experiments designed to assay microglial response to nanoparticles and exposure of hypothalamic neurons to supernatant from activated microglia to determine neurotoxicity.
09:17
Surrogate Model Development for Digital Experiments in Welding
0 Views •
Cited by 2 •
2025
This protocol outlines a general workflow for constructing an artificial neural network for welding simulation using datasets generated automatically through Python scripts with macro functions. The workflow is validated against a benchmark case involving single-pass, straight-line welding. The surrogate model's predictive accuracy shows a strong agreement with finite element simulations.
05:58
Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
0 Views •
Cited by 7 •
2019
This protocol describes how to perform rapid low-cost luciferase assays at medium-throughput using an insulin-linked Gaussia luciferase as a proxy for insulin secretion from beta cells. The assay can be performed with most luminescence plate readers and multichannel pipettes.
03:51
Determining Nanoparticle-Induced Toxicity in Neurons Using Microglia as a Surrogate Biosensor
0 Views •
2025
This video demonstrates a method to assess the neurotoxic effects of nanoparticles using microglia. It outlines the steps for activating microglia with nanoparticles, filtering conditioned media to isolate microglia-derived pro-inflammatory cytokines, and testing hypothalamic neuron toxicity with the conditioned media.
FAQs
Selection should focus on properties that influence the analytical response, rather than on superficial resemblance to the biological specimen. Researchers choose a substitute that approximates the authentic sample’s relevant chemical and physical characteristics, then examine its behavior in the assay. This comparison helps determine whether it can support dependable calibration and quality-control measurements.
Comparing analytical responses between the surrogate and authentic matrix shows whether the substitute changes assay behavior. A difference may indicate that the surrogate does not adequately reproduce relevant matrix characteristics, potentially affecting measured drug concentrations. This assessment is important because matrix-related differences can introduce bias and weaken confidence in quantitative bioanalysis.
Validation demonstrates that the substitute does not compromise the assay’s performance. Key considerations include accuracy, precision, selectivity, and stability, because each can influence whether reported drug concentrations are dependable. Establishing acceptable performance gives researchers evidence that results generated with the surrogate matrix remain suitable for the intended pharmacological analysis.
Researchers first select and prepare the substitute material, then prepare calibration standards and quality-control samples within that matrix. The assay responses are evaluated and compared with those associated with the authentic biological sample or expected assay behavior. Validation follows to determine whether the approach supports reliable measurement without unacceptable analytical bias.
This approach is useful when drug-free authentic matrix is difficult to obtain or is unsuitable for assay development. It can make quantitative bioanalysis feasible while researchers measure drug concentrations in biological specimens. Its value is greatest when validation confirms that the substitute maintains acceptable assay performance for the intended development studies.
A validated approach can support calibration, quality-control assessment, and quantitative measurement of drug concentrations in biological specimens. It also provides evidence about assay performance when authentic matrix access is limited. In pharmacology, these results help determine whether a bioanalytical method can produce interpretable concentration data during drug development without introducing unacceptable effects from the substitute material.